Increased levels of retinol binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement

Circulation Journal

Volumn 76, Issue 9, 2012, Pages 2148-2152

  Chavarria, Nelson ^a   Kato, Tomoko S ^a   Khan, Raffay ^a   Chokshi, Aalap ^a   Collado, Elias ^a   Akashi, Hirokazu ^a   Takayama, Hiroo ^a   Naka, Yoshifumi ^a   Farr, Maryjane ^a   Mancini, Donna ^a   Christian Schulze, P ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Heart failure; Insulin resistance; Retinol binding protein 4; Ventricular assist device

Indexed keywords

BILIRUBIN GLUCURONIDE; BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN A1C; RETINOL BINDING PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART FAILURE; HEMODYNAMIC PARAMETERS; HOMEOSTASIS; HUMAN; IMPLANTATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; INSULIN; MALE; MIDDLE AGED; RETINOL-BINDING PROTEINS, PLASMA;

EID: 84865504663     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0350     Document Type: Article

References (20)

1. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS, Oliver MF. Insulin resistance in chronic heart failure. Eur Heart J 1994; 15: 1528-1532.
2. McGaffin KR, Moravec CS, McTiernan CF. Leptin signaling in the failing and mechanically unloaded human heart. Circ Heart Fail 2009; 2: 676-683.
3. Torre-Amione G, Stetson SJ, Youker KA, Durand JB, Radovancevic B, Delgado RM, et al. Decreased expression of tumor necrosis factor-α in failing human myocardium after mechanical circulatory support. Circulation 1999; 100: 1189-1193.
4. Van Berendoncks AM, Garnier A, Beckers P, Hoymans VY, Possemiers N, Fortin D, et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail 2010; 3: 185-194.
5. Butler J, Kalogeropoulos A, Georgiopoulou V, de Rekeneire N, Rodondi N, Smith AL, et al. Serum resistin concentrations and risk of new onset heart failure in older persons: The Health, Aging, and Body Composition (Health ABC Study). Arterioscler Thromb Vasc Biol 2009; 29: 1144-1149.
6. AlZadjali MA, Godfrey V, Khan F, Choy A, Doney AS, Wong AK, et al. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol 2009; 53: 747-753.
7. Esteve E, Ricart W, Fernandez-Real JM. Adipocytokines and insulin resistance: The possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 2009; 32: S362-S367.
8. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356-362.
9. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354: 2552-2563.
10. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, et al. Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 2007; 92: 2590-2597.
11. Bobbert P, Weithäuser A, Anders J, Bobbert T, Kühl U, Schultheiss HP, et al. Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy. Eur J Heart Fail 2009; 11: 1163-1168.
12. Uriel N, Naka Y, Colombo PC, Farr M, Pak SW, Cotarlan V, et al. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices. Eur J Heart Fail 2011; 13: 195-199.
13. Goldestein DJ, Moazami N, Seldomridge AJ, Laio H, Ashton RC, Naka Y, et al. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg 1997; 63: 971-974.
14. Corry DC, DeLucia A, Zhu H, Radcliffe RR, Brevetti GF, El-Khatib H, et al. Time course of cytokine release and complement activation after implantation of the HeartMate left ventricular assist device. ASAIO J 1998; 44: M347-M351.
15. Yamaguchi T, Sawa Y, Masai T, Nishimura M, Chang JC, Nishida T, et al. Hepatic sinusoid endothelial dysfunction plays a role in hyperbilirubinemia in patients following implantation of an LVAD. ASAIO J 1997; 43: M449-M452.
16. Burkhoff D, Holmes JW, Madigan J, Barbone A, Oz MC. Left ventricular assist device-induced reverse ventricular remodeling. Prog Cardiovasc Dis 2000; 43: 19-26.
17. Xydas S, Rosen RS, Ng C, Mercando M, Cohen J, DiTullio M, et al. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant 2006; 25: 7-15.
18. Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, Pagani FD, et al. Cardiac improvement during mechanical circulatory support: A prospective multicenter study of the LVAD Working Group. Circulation 2007; 115: 2497-2505.
19. Takebayashi K, Sohma R, Aso Y, Inukai T. Effects of retinol binding protein 4 on vascular endothelial cells. Biochem Biophys Res Commun 2011; 408: 58-64.
20. Chen JX, Meyrick B. Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium. Lab Invest 2004; 84: 182-190.